Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 42

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

IL-1 Antagonism in Men With Metabolic Syndrome and Low Testosterone: A Randomized Clinical Trial

Ebrahimi, Fahim, Urwyler, Sandrine A, Straumann, Sven, Doerpfeld, Simone, Bernasconi, Luca, Neyer, Peter, Schuetz, Philipp, Mueller, Beat, Donath, Marc Y, Christ-Crain, Mirjam·2018·The Journal of Clinical Endocrinology & Metabolism
DOI 10.1210/jc.2018-00739
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2018-00739

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 33

  1. Dhindsa, 2004, Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes, J Clin Endocrinol Metab, 89, 5462
  2. Ding, 2006, Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis, JAMA, 295, 1288
  3. Nguyen, 2015, Testosterone and “age-related hypogonadism”—FDA concerns, N Engl J Med, 373, 689
  4. Atlantis, 2013, Endogenous testosterone level and testosterone supplementation therapy in chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis, BMJ Open, 3, e003127
  5. Smith, 2005, Cortisol, testosterone, and coronary heart disease: prospective evidence from the Caerphilly study, Circulation, 112, 332
  6. Spranger, 2003, Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study, Diabetes, 52, 812
  7. Dinarello, 2011, Interleukin-1 in the pathogenesis and treatment of inflammatory diseases, Blood, 117, 3720
  8. Dinarello, 2012, Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases, Nat Rev Drug Discov, 11, 633
  9. Ridker, 2017, Antiinflammatory therapy with canakinumab for atherosclerotic disease, N Engl J Med, 377, 1119
  10. Leong, 2015, Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study, Lancet, 386, 266
  11. Mohamed, 2010, The quantitative ADAM questionnaire: a new tool in quantifying the severity of hypogonadism, Int J Impot Res, 22, 20
  12. Rosen, 1997, The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction, Urology, 49, 822
  13. Penner, 2009, The fatigue scale for motor and cognitive functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue, Mult Scler, 15, 1509
  14. Urwyler, 2017, Interleukin-1 antagonism decreases cortisol levels in obese individuals, J Clin Endocrinol Metab, 102, 1712
  15. Vermeulen, 1999, A critical evaluation of simple methods for the estimation of free testosterone in serum, J Clin Endocrinol Metab, 84, 3666
  16. Ridker, 2018, Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial, Lancet, 391, 319
  17. Cawthorne, 2011, Biodistribution, pharmacokinetics and metabolism of interleukin-1 receptor antagonist (IL-1RA) using [18F]-IL1RA and PET imaging in rats, Br J Pharmacol, 162, 659
  18. Skinner, 2009, Transport of interleukin-1 across cerebromicrovascular endothelial cells, Br J Pharmacol, 156, 1115
  19. Herman, 2013, LPS-induced inflammation potentiates the IL-1β-mediated reduction of LH secretion from the anterior pituitary explants, Clin Dev Immunol, 2013, 926937
  20. Zoli, 2002, ACTH, cortisol and prolactin in active rheumatoid arthritis, Clin Rheumatol, 21, 289
  21. Calkins, 1990, Differential effects of recombinant interleukin-1α and β on Leydig cell function, Biochem Biophys Res Commun, 167, 548
  22. Hales, 1998, Arginine vasopressin inhibition of cytochrome P450c17 and testosterone production in mouse Leydig cells, Endocrine, 8, 19
  23. Libby, 2002, Inflammation and atherosclerosis, Circulation, 105, 1135
  24. Zhang, 2016, Interleukin-1 receptor activation potentiates salt reabsorption in angiotensin II-induced hypertension via the NKCC2 co-transporter in the nephron, Cell Metab, 23, 360
  25. Westbury, 2018, Relationships between markers of inflammation and muscle mass, strength and function: findings from the Hertfordshire cohort study, Calcif Tissue Int, 102, 287
  26. Chung, 2007, Effects of testosterone and nandrolone on cardiac function: a randomized, placebo-controlled study, Clin Endocrinol (Oxf), 66, 235
  27. Roerink, 2017, Cytokine inhibition in patients with chronic fatigue syndrome: a randomized trial, Ann Intern Med, 166, 557
  28. Haren, 2005, Effect of 12 month oral testosterone on testosterone deficiency symptoms in symptomatic elderly males with low-normal gonadal status, Age Ageing, 34, 125
  29. Morales, 2009, Androgens and sexual function: a placebo-controlled, randomized, double-blind study of testosterone vs. dehydroepiandrosterone in men with sexual dysfunction and androgen deficiency, Aging Male, 12, 104
  30. Everett, 2018, Anti-inflammatory therapy with canakinumab for the prevention and management of diabetes, J Am Coll Cardiol, 71, 2392
  31. Cohen, 2002, Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial, Arthritis Rheum, 46, 614
  32. Kaiser, 2012, Injection-site reactions upon Kineret (anakinra) administration: experiences and explanations, Rheumatol Int, 32, 295
  33. van Asseldonk, 2011, Treatment with anakinra improves disposition index but not insulin sensitivity in nondiabetic subjects with the metabolic syndrome: a randomized, double-blind, placebo-controlled study, J Clin Endocrinol Metab, 96, 2119

Cited by

See all 42

Metadata

Authors
Ebrahimi, F., Urwyler, S. A., Straumann, S., Doerpfeld, S., Bernasconi, L., Neyer, P., Schuetz, P., Mueller, B., Donath, M. Y., & Christ-Crain, M.
Affiliations
  • Division of Endocrinology, Diabetes, and Clinical Nutrition, Department of Internal Medicine, University of Basel Hospital, Basel, Switzerland
  • Department of Laboratory Medicine, Kantonsspital Aarau, Aarau, Switzerland
  • Department of Clinical Research, University of Basel Hospital, Basel, Switzerland
Venue
The Journal of Clinical Endocrinology & Metabolism
Publisher
The Endocrine Society
Published
2018-06-22
Volume
103
Issue
9
Pages
3466-3476
ISSN
  • 0021-972X
  • 1945-7197
DOI
10.1210/jc.2018-00739
Cited by
42
References
10
Language
en
Funders
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (PP00P3-12346)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: IL-1 Antagonism in Men With Metabolic Syndrome and Low Testosterone: A Randomized Clinical Trial. https://app.cochat.ai/papers/10.1210/jc.2018-00739
The paper
Ebrahimi, F., Urwyler, S. A., Straumann, S., Doerpfeld, S., Bernasconi, L., Neyer, P., Schuetz, P., Mueller, B., Donath, M. Y., & Christ-Crain, M. (2018). IL-1 Antagonism in Men With Metabolic Syndrome and Low Testosterone: A Randomized Clinical Trial. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2018-00739

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.